Lung cancer is one of the most serious oncological diseases in the world. Treatment of this disease can be complicated, and results vary depending on the stage of the disease. One of the latest advances in radiation therapy is SABR (Stereotactic Ablative Body Radiotherapy) technology, which allows very precise irradiation of the tumor. In this article, we present the story of a patient on whom SABR therapy was used to treat lung cancer.
Diagnosis
Jan, a 65-year-old retired mechanic, complained of a chronic cough that did not go away despite treatment. After a series of tests, including a chest CT scan, he was diagnosed with lung cancer. Since the tumor was at an early stage and small in size, doctors decided that John was a good candidate for SABR therapy.
What is SABR?
SABR is a radiation therapy technique that allows high doses of radiation to be delivered very precisely to the tumor while minimizing the exposure of healthy tissue. This is especially important for lung cancer, where the tissues and organs surrounding the lung are very sensitive to radiation.
SABR therapy
Jan underwent a short cycle of SABR therapy, which consisted of one session of radiation. The procedure was safe and went without any serious side effects. Jan experienced some fatigue, but this was easily managed by the patient and his medical team.
Post-treatment follow-up
After SABR therapy, Jan remained under regular follow-up with his oncologist. Follow-up examinations showed that the tumor had begun to shrink, and after a few months it was no longer visible on CT images. Jan's respiratory symptoms also improved markedly.
Conclusions
SABR therapy was a key factor that helped Jan in his fight against lung cancer. Thanks to this innovative technology, Jan was able to effectively treat his cancer with minimal impact on his daily life. His story shows how technological advances in radiation therapy can have a real impact on patients' lives and their ability to beat cancer. Anticipated future advancements in radiation therapy only make the prospects for patients like Jan even brighter.
